WHO invites makers of mpox tests for emergency review in push for rapid access
Adds details and background throughout
Aug 29 (Reuters) -The World Health Organization on Thursday sought to speed up theaccess to diagnostic tests for mpox by askingmanufacturers to submit their products for an emergencyreview.
The agency has been in discussions with manufacturers about the need for effective diagnostics, particularly in low-income groups.
To expand access to diagnostic services urgently, the WHOhas called for submissions from manufacturers forEmergency Use Listing that would allow it toapprove medical products such as vaccines, tests and treatments.
The process aims to assist countries to procure the critically needed products such as tests through UN agencies and other partners.
A new form of the virus has triggered global concern as it seems to spread easily though routine close contact, prompting the health agencyto declare mpox a global public health emergency earlier thismonth.
Sweden and Thailand have confirmed cases of the clade Ib type of the virus, outside of the Democratic Republic of Congo and neighboring countries.
With as many as 1,000 suspected cases reported in the Congo alone this week, the need for diagnostic tests has surged dramatically, the agencysaid.
In the coming weeks, it will deliver another 30,000 tests to African countries.
The WHOhas also updated its diagnostic testing guidance to detect the new virus strain and is working with counties to roll it out.
Manufacturers of in-vitrodiagnostics have been asked to provide available data on the quality, safety and performance of the tests to the WHO as soon as possible.
Earlier this week, diagnostics firm Labcorp LH.N said it is working with U.S. health regulators to determine if it needed to ramp up its mpox testing capacity.
Swiss drugmaker Roche ROG.S is actively working to enhance laboratory testing capacity for mpox worldwide.
Reporting by Sriparna Roy in Bengaluru; Editing by Mohammed Safi Shamsi and Arun Koyyur
免责声明: XM Group仅提供在线交易平台的执行服务和访问权限，并允许个人查看和/或使用网站或网站所提供的内容，但无意进行任何更改或扩展，也不会更改或扩展其服务和访问权限。所有访问和使用权限，将受下列条款与条例约束：(i) 条款与条例；(ii) 风险提示；以及(iii) 完整免责声明。请注意，网站所提供的所有讯息，仅限一般资讯用途。此外，XM所有在线交易平台的内容并不构成，也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容，包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接，皆保持不变，并作为一般市场评论所提供，而非投资性建议。所有在线交易平台所发布的资料，仅适用于教育/资讯类用途，不包含也不应被视为适用于金融、投资税或交易相关咨询和建议，或是交易价格纪录，或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解，XM非独立投资研究提示和风险提示相关资讯，更多详情请点击 这里。
